Biotech reporter Max Stendahl joins necn to discuss his story, "Pricey gene therapies expected to ‘dominate’ talk at J.P. Morgan conference."
Biotech reporter Max Stendahl joins necn to discuss his story, "Pricey gene therapies expected to ‘dominate’ talk at J.P. Morgan conference."